BIOMAT Database Logo BIOMAT Database Logo

Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients. 2006

Jo I V Lenaers, and Maarten H L Christiaans, and Christina E M Voorter, and Hans P van Hooff, and Ella M van den Berg-Loonen
Tissue Typing Laboratory, University Hospital Maastricht, the Netherlands.

BACKGROUND De novo development of anti-human leukocyte antigen (HLA) antibodies after transplantation is associated with increased rejection and decreased graft survival. In this study, the effect of posttransplant HLA antibodies on clinical outcome was evaluated in patients treated with tacrolimus by means of flow cytometric crossmatches (FCXm). METHODS T- and B-cell FCXm were performed retrospectively on posttransplant sera of patients who received a graft between 1997 and 1999. Ninety-four kidney-only recipients were tested and all FCXm positive sera were investigated for the presence of HLA class I and II antibodies by Flow panel reactive antibodies. RESULTS From 94 patients with a negative pretransplant complement-dependent cytotoxicity crossmatch, seven (7%) showed a positive pretransplant FCXm. After transplantation the FCXm became positive in five patients (6%). The predictive value of a positive FCXm after transplantation, and the log-transformed relative change in fluorescence ratio between pretransplant and posttransplant serum, were not significant to rejection within six months, nor to graft survival censored for death. CONCLUSIONS The presence of HLA antibodies before rejection or graft failure could only be shown in a minority of patients; most antibodies were detected after graft failure, especially after transplantectomy. Monitoring through antibody testing after transplantation on the basis of our results has no added value with tacrolimus-based immunosuppression.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human

Related Publications

Jo I V Lenaers, and Maarten H L Christiaans, and Christina E M Voorter, and Hans P van Hooff, and Ella M van den Berg-Loonen
Clinical relevance of pretransplant flow cytometric crossmatches with T and B lymphocytes in kidney transplantation.
August 1990, Transplantation proceedings,
Jo I V Lenaers, and Maarten H L Christiaans, and Christina E M Voorter, and Hans P van Hooff, and Ella M van den Berg-Loonen
Relevance of "remote positive" crossmatches and positive B-cell crossmatches in renal transplantation.
August 1990, Transplantation proceedings,
Jo I V Lenaers, and Maarten H L Christiaans, and Christina E M Voorter, and Hans P van Hooff, and Ella M van den Berg-Loonen
Flow cytometric evaluation of posttransplant B-cell lymphoproliferative disorders.
February 2004, Archives of pathology & laboratory medicine,
Jo I V Lenaers, and Maarten H L Christiaans, and Christina E M Voorter, and Hans P van Hooff, and Ella M van den Berg-Loonen
Cytotoxic crossmatches in renal transplant patients by conventional cytotoxicity, immunomagnetic cell separation, and flow cytometry.
August 1990, Transplantation proceedings,
Jo I V Lenaers, and Maarten H L Christiaans, and Christina E M Voorter, and Hans P van Hooff, and Ella M van den Berg-Loonen
Lack of correlation between IgG T-lymphocyte flow cytometric crossmatches with primary renal allograft outcome.
January 1992, Transplant international : official journal of the European Society for Organ Transplantation,
Jo I V Lenaers, and Maarten H L Christiaans, and Christina E M Voorter, and Hans P van Hooff, and Ella M van den Berg-Loonen
Comparison of two drug regimens upon clinical outcome among renal transplant recipients with positive flow cytometric crossmatches.
August 2002, Clinical transplantation,
Jo I V Lenaers, and Maarten H L Christiaans, and Christina E M Voorter, and Hans P van Hooff, and Ella M van den Berg-Loonen
Renal allograft survival in CSA-treated patients with positive donor-specific B cell crossmatches.
February 1989, Transplantation proceedings,
Jo I V Lenaers, and Maarten H L Christiaans, and Christina E M Voorter, and Hans P van Hooff, and Ella M van den Berg-Loonen
Positive B cell crossmatches in highly sensitized patients--influence of antibody specificity on renal transplant outcome.
February 1987, Transplantation proceedings,
Jo I V Lenaers, and Maarten H L Christiaans, and Christina E M Voorter, and Hans P van Hooff, and Ella M van den Berg-Loonen
Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus.
May 2002, Journal of the American Society of Nephrology : JASN,
Jo I V Lenaers, and Maarten H L Christiaans, and Christina E M Voorter, and Hans P van Hooff, and Ella M van den Berg-Loonen
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
December 1999, Transplantation,
Copied contents to your clipboard!